Patients With Chronic Hepatitis C Virus Infection Are at an Increased Risk of Colorectal Cancer: A Nationwide Population-Based Case-Control Study in Taiwan.

case-control study colorectal cancer hepatitis C virus insurance data population-based

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 13 05 2020
accepted: 25 11 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: epublish

Résumé

Studies evaluating colorectal cancer (CRC) risk associated with chronic hepatitis C virus (HCV) infection are limited. In this case-control study, we identify 67,670 CRC cases newly diagnosed from 2005 to 2011 and randomly selected 67,670 controls without HCV and CRC from the same database, frequency matched by age and sex of cases. Results of logistic regression analysis revealed that the adjusted odds ratio (aOR) of CRC was 1.16 (95% confidence interval [CI] = 1.08-1.24, p < 0.001) in association with chronic HCV. The CRC risk was slightly greater for women than for men. The risk decreased with age, with the aOR decreased from 2.26 (95% CI = 1.32-3.87, p = 0.003) in patients under 45 years old to 1.31 (95% CI = 1.10-1.55, p = 0.03) in patients aged 50-59, and 1.10 (95% CI = 1.00-1.22, p = 0.061) in patients aged over 70. Our findings suggested that patients with chronic HCV infection are at an elevated risk of developing CRC. Our data also imply that the CRC prevention programs are needed to target younger HCV patients.

Identifiants

pubmed: 33489873
doi: 10.3389/fonc.2020.561420
pmc: PMC7819899
doi:

Types de publication

Journal Article

Langues

eng

Pagination

561420

Informations de copyright

Copyright © 2021 Su, Bai, Le, Muo, Chang, Te, Sung and Yeh.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Med Virol. 2001 Sep;65(1):58-65
pubmed: 11505444
BMJ Open. 2012 Oct 07;2(5):
pubmed: 23045358
Liver Int. 2011 Jul;31 Suppl 2:61-80
pubmed: 21651703
J Hepatol. 2006 Aug;45(2):197-203
pubmed: 16684579
J Hepatol. 2014 Feb;60(2):253-9
pubmed: 24096049
Adv Exp Med Biol. 2017;1018:129-146
pubmed: 29052135
BMC Cancer. 2011 Nov 24;11:495
pubmed: 22115285
Cell Host Microbe. 2014 Mar 12;15(3):266-82
pubmed: 24629334
Hepatology. 2013 Apr;57(4):1333-42
pubmed: 23172780
Gut. 2011 May;60(5):688-94
pubmed: 21068131
World J Gastroenterol. 2007 May 7;13(17):2436-41
pubmed: 17552026
J Hepatol. 2014 Nov;61(1 Suppl):S45-57
pubmed: 25086286
Hepatol Int. 2016 May;10(3):415-23
pubmed: 26660706
Am J Gastroenterol. 2019 Feb;114(2):322-329
pubmed: 30694865
Clin Microbiol Infect. 2009 Nov;15(11):964-70
pubmed: 19874379
Eur J Intern Med. 2006 Aug;17(5):325-9
pubmed: 16864006
Int J Colorectal Dis. 2014 Jan;29(1):75-80
pubmed: 23982424
Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443-50
pubmed: 16896030
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):283-290
pubmed: 29339810
World J Gastroenterol. 2015 Dec 7;21(45):12896-953
pubmed: 26668515
J Gastrointest Oncol. 2016 Aug;7(4):609-14
pubmed: 27563452
Viruses. 2020 Jan 14;12(1):
pubmed: 31947702
Semin Oncol. 2014 Dec;41(6):860-75
pubmed: 25499643
J Formos Med Assoc. 2020 Jan;119(1 Pt 3):413-419
pubmed: 31420113
Annu Rev Pathol. 2009;4:399-415
pubmed: 18928409
Clin Epidemiol. 2010 Aug 09;2:179-86
pubmed: 20865115
Nat Rev Dis Primers. 2015 Nov 05;1:15065
pubmed: 27189416
Med J Aust. 2016 Apr 18;204(7):268-72
pubmed: 27078601
London J Prim Care (Abingdon). 2010 Dec;3(2):115-9
pubmed: 25949636
Medicine (Baltimore). 2016 Apr;95(15):e3284
pubmed: 27082566
Cancer Lett. 2016 Feb 1;371(1):107-16
pubmed: 26620707
Future Microbiol. 2006 Jun;1(1):103-12
pubmed: 17661689
Int J Oncol. 2007 Aug;31(2):269-75
pubmed: 17611682
J Formos Med Assoc. 2007 Feb;106(2):148-55
pubmed: 17339159
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
World J Gastroenterol. 2000 Dec;6(6):805-811
pubmed: 11819700
J Hepatol. 2015 Oct;63(4):822-8
pubmed: 25937437
Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):122-132
pubmed: 27924080
Am J Gastroenterol. 2007 Jun;102(6):1237-43
pubmed: 17531012

Auteurs

Fu-Hsiung Su (FH)

Department of Family Medicine, Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.
School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.

Chyi-Huey Bai (CH)

School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.

Thi Nga Le (TN)

International Master/PhD Program, College of Medicine, Taipei Medical University, Taipei City, Taiwan.

Chih-Hsin Muo (CH)

Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.

Shih-Ni Chang (SN)

Big Data Center, China Medical University Hospital, Taichung, Taiwan.
The Ph.D. Program for Cancer Biology and Drug Discovery, School of Medicine, China Medical University, Taichung, Taiwan.

Arlene Te (A)

Department of Family Medicine, Cardinal Tien Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.
School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.

Fung-Chang Sung (FC)

Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
Department of Health Services Administration, College of Public Health, China Medical University, Taichung, Taiwan.
Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan.

Chih-Ching Yeh (CC)

School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.
Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan.
Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Master Program in Applied Molecular Epidemiology, College of Public Health, Taipei Medical University, Taipei, Taiwan.

Classifications MeSH